Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Thoughts & Musings

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Jun 18, 2021 9:41am

149 Views

Post# 33410510

RE:RE:Thoughts & Musings

The stock could run to $30.00 and I will still vote against the SOB.

Dareg wrote: Even if we get fabulous news, nobody here owes Howie any apology. The lack of commuication, transparency and detail is unacceptable. He is running this PUBLICLY traded company as though it were his very own PRIVATE venture.

My biggest fear is that any good news , followed by a rise in the SP, will see many of the longtime faithful abandon ship. Shareholders can only take so much pain before they run screaming for the exits .

Now, Cue the cheerleaders......

<< Previous

Bullboard Posts

Next >>

How to decrease sector risk by owning hundreds of mineral assets